Operator
Good day, ladies and gentlemen, and welcome to the COMPASS Pathways fourth-quarter 2020 conference call. [Operator instructions] As a reminder, this call is being recorded. I would now like to introduce your host for today s conference, Steven Schultz, senior vice president of investor relations. You may begin.
Steve Schultz
Senior Vice President of Investor Relations
Thank you, operator, and welcome all of you, and thank you for joining us today for our fourth quarter and full-year 2020 results call. This is Steve Schultz, senior vice president investor relations at COMPASS Pathways. And today, I m joined by George Goldsmith, chairman and chief executive officer; and Piers Morgan, chief financial officer. George will begin today s call with a business update on our recent progress.
New tumor-penetrating therapy may improve outcomes in patients with pancreatic cancer
Every 12 minutes, someone in the United States dies of pancreatic cancer, which is often diagnosed late, spreads rapidly and has a five-year survival rate at approximately 10 percent. Treatment may involve radiation, surgery and chemotherapy, though often the cancer becomes resistant to drugs.
Researchers at University of California San Diego School of Medicine and Moores Cancer Center, in collaboration with Sanford-Burnham-Prebys Medical Discovery Institute and Columbia University, demonstrated that a new tumor-penetrating therapy, tested in animal models, may enhance the effects of chemotherapy, reduce metastasis and increase survival.
The study, published online March 9, 2021 in
E-Mail
A gene therapy for chronic pain could offer a safer, non-addictive alternative to opioids. Researchers at the University of California San Diego developed the new therapy, which works by temporarily repressing a gene involved in sensing pain. It increased pain tolerance in mice, lowered their sensitivity to pain and provided months of pain relief without causing numbness.
The researchers report their findings in a paper published Mar. 10 in
Science Translational Medicine.
The gene therapy could be used to treat a broad range of chronic pain conditions, from lower back pain to rare neuropathic pain disorders conditions for which opioid painkillers are the current standard of care.
Wisdom Counters Loneliness-Associated Neural Processing, Brain Imaging Biomarker Study Finds
March 9, 2021
Share
Even before the mandate of social distancing, loneliness in the midst or far from the madding crowd has been undermining our mental and physical health. The loss of meaningful interpersonal connections has become so common that “loneliness epidemic” is common parlance. “Loneliness puts us at a greater risk of coronary heart disease, dementia and depression,” says Vivek H Murthy, the 19th surgeon general of the United States and Biden’s nominee to be the 21
st, in his book
Together: Loneliness, Health and What Happens When We Find Connection.
E-Mail
IMAGE: Andrew Lowy, MD, is the co-corresponding author of the study, professor of surgery at UC San Diego School of Medicine and chief of the Division of Surgical Oncology at Moores. view more
Credit: UC San Diego Health Sciences
Every 12 minutes, someone in the United States dies of pancreatic cancer, which is often diagnosed late, spreads rapidly and has a five-year survival rate at approximately 10 percent. Treatment may involve radiation, surgery and chemotherapy, though often the cancer becomes resistant to drugs.
Researchers at University of California San Diego School of Medicine and Moores Cancer Center, in collaboration with Sanford-Burnham-Prebys Medical Discovery Institute and Columbia University, demonstrated that a new tumor-penetrating therapy, tested in animal models, may enhance the effects of chemotherapy, reduce metastasis and increase survival.